HEADER CELL CYCLE 19-JUN-18 6GU4 TITLE CDK1/CYCLINB/CKS2 IN COMPLEX WITH CGP74514A COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDK1,CELL DIVISION CONTROL PROTEIN 2 HOMOLOG,CELL DIVISION COMPND 5 PROTEIN KINASE 1,P34 PROTEIN KINASE; COMPND 6 EC: 2.7.11.22,2.7.11.23; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: G2/MITOTIC-SPECIFIC CYCLIN-B1; COMPND 10 CHAIN: B; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: CYCLIN-DEPENDENT KINASES REGULATORY SUBUNIT 2; COMPND 14 CHAIN: C; COMPND 15 SYNONYM: CKS-2; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK1, CDC2, CDC28A, CDKN1, P34CDC2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PVL1393; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CCNB1, CCNB; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 19 MOL_ID: 3; SOURCE 20 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 21 ORGANISM_COMMON: HUMAN; SOURCE 22 ORGANISM_TAXID: 9606; SOURCE 23 GENE: CKS2; SOURCE 24 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 25 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CDK1, CYCLINB1, CKS2, INHIBITOR, CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR D.J.WOOD,S.KOROLCHUK,N.J.TATUM,L.Z.WANG,J.A.ENDICOTT,M.E.M.NOBLE, AUTHOR 2 M.P.MARTIN REVDAT 4 17-JAN-24 6GU4 1 REMARK REVDAT 3 30-JAN-19 6GU4 1 JRNL REVDAT 2 26-DEC-18 6GU4 1 COMPND SOURCE DBREF SEQADV REVDAT 1 05-DEC-18 6GU4 0 JRNL AUTH D.J.WOOD,S.KOROLCHUK,N.J.TATUM,L.Z.WANG,J.A.ENDICOTT, JRNL AUTH 2 M.E.M.NOBLE,M.P.MARTIN JRNL TITL DIFFERENCES IN THE CONFORMATIONAL ENERGY LANDSCAPE OF CDK1 JRNL TITL 2 AND CDK2 SUGGEST A MECHANISM FOR ACHIEVING SELECTIVE CDK JRNL TITL 3 INHIBITION. JRNL REF CELL CHEM BIOL V. 26 121 2019 JRNL REFN ESSN 2451-9448 JRNL PMID 30472117 JRNL DOI 10.1016/J.CHEMBIOL.2018.10.015 REMARK 2 REMARK 2 RESOLUTION. 2.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 83.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 19176 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 989 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.73 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1378 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3200 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5139 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 76 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.44000 REMARK 3 B22 (A**2) : -2.04000 REMARK 3 B33 (A**2) : 3.49000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.367 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.914 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5292 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5013 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7158 ; 1.522 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11638 ; 3.637 ; 2.993 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 627 ; 6.890 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 238 ;38.661 ;23.697 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 970 ;17.674 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 32 ;20.414 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 787 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5729 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1066 ; 0.006 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2517 ; 3.090 ; 5.053 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2516 ; 3.083 ; 5.052 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3141 ; 5.033 ; 7.569 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3142 ; 5.033 ; 7.571 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2775 ; 3.254 ; 5.467 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2775 ; 3.254 ; 5.467 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 4018 ; 5.425 ; 8.040 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5958 ; 8.098 ;58.488 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5959 ; 8.097 ;58.487 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6GU4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010563. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20165 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.730 REMARK 200 RESOLUTION RANGE LOW (A) : 83.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.27000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4Y72 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES/IMIDAZOLE BUFFER (PH6.7), REMARK 280 6.5% MPD, 5% PEG4K, 10% PEG1K PROTEIN AT 10-12 MG/ML + 0.5MM REMARK 280 INHIBITOR, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.25650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 83.04300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.10250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 83.04300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.25650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.10250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A 290 REMARK 465 ASP A 291 REMARK 465 ASN A 292 REMARK 465 GLN A 293 REMARK 465 ILE A 294 REMARK 465 LYS A 295 REMARK 465 LYS A 296 REMARK 465 MET A 297 REMARK 465 GLY B 160 REMARK 465 SER B 161 REMARK 465 HIS B 162 REMARK 465 MET B 163 REMARK 465 ASN B 164 REMARK 465 LEU B 165 REMARK 465 ALA B 430 REMARK 465 LYS B 431 REMARK 465 VAL B 432 REMARK 465 GLY C -4 REMARK 465 PRO C -3 REMARK 465 LEU C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 LYS C 75 REMARK 465 ASP C 76 REMARK 465 GLN C 77 REMARK 465 GLN C 78 REMARK 465 LYS C 79 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 7 -61.94 -96.22 REMARK 500 GLU A 38 -82.40 -63.83 REMARK 500 LEU A 58 65.18 -103.90 REMARK 500 GLN A 72 -83.30 -99.44 REMARK 500 ARG A 127 -1.83 69.57 REMARK 500 ASP A 128 41.57 -144.53 REMARK 500 ASP A 146 78.20 53.63 REMARK 500 HIS A 162 -8.74 -59.84 REMARK 500 VAL A 164 100.35 -51.90 REMARK 500 VAL A 165 -56.41 -20.85 REMARK 500 SER A 182 -152.02 -155.24 REMARK 500 HIS A 205 54.60 -100.77 REMARK 500 TRP A 228 86.36 -167.61 REMARK 500 GLU A 230 -2.52 63.81 REMARK 500 SER A 248 73.19 -64.73 REMARK 500 LEU A 249 -53.35 -122.32 REMARK 500 PHE A 287 73.67 -112.19 REMARK 500 ASN B 274 18.39 58.29 REMARK 500 VAL B 314 103.33 37.09 REMARK 500 ASP B 356 -3.30 67.95 REMARK 500 LEU B 414 123.81 -39.57 REMARK 500 ASP C 14 -148.56 -121.97 REMARK 500 VAL C 48 95.72 -64.67 REMARK 500 SER C 51 166.81 -33.31 REMARK 500 ARG C 71 118.75 -169.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FC8 A 301 DBREF 6GU4 A 1 297 UNP P06493 CDK1_HUMAN 1 297 DBREF 6GU4 B 164 432 UNP P14635 CCNB1_HUMAN 165 433 DBREF 6GU4 C 1 79 UNP P33552 CKS2_HUMAN 1 79 SEQADV 6GU4 GLY A -4 UNP P06493 EXPRESSION TAG SEQADV 6GU4 PRO A -3 UNP P06493 EXPRESSION TAG SEQADV 6GU4 LEU A -2 UNP P06493 EXPRESSION TAG SEQADV 6GU4 GLY A -1 UNP P06493 EXPRESSION TAG SEQADV 6GU4 SER A 0 UNP P06493 EXPRESSION TAG SEQADV 6GU4 GLY B 160 UNP P14635 EXPRESSION TAG SEQADV 6GU4 SER B 161 UNP P14635 EXPRESSION TAG SEQADV 6GU4 HIS B 162 UNP P14635 EXPRESSION TAG SEQADV 6GU4 MET B 163 UNP P14635 EXPRESSION TAG SEQADV 6GU4 SER B 166 UNP P14635 CYS 167 ENGINEERED MUTATION SEQADV 6GU4 SER B 237 UNP P14635 CYS 238 ENGINEERED MUTATION SEQADV 6GU4 SER B 349 UNP P14635 CYS 350 ENGINEERED MUTATION SEQADV 6GU4 GLY C -4 UNP P33552 EXPRESSION TAG SEQADV 6GU4 PRO C -3 UNP P33552 EXPRESSION TAG SEQADV 6GU4 LEU C -2 UNP P33552 EXPRESSION TAG SEQADV 6GU4 GLY C -1 UNP P33552 EXPRESSION TAG SEQADV 6GU4 SER C 0 UNP P33552 EXPRESSION TAG SEQRES 1 A 302 GLY PRO LEU GLY SER MET GLU ASP TYR THR LYS ILE GLU SEQRES 2 A 302 LYS ILE GLY GLU GLY THR TYR GLY VAL VAL TYR LYS GLY SEQRES 3 A 302 ARG HIS LYS THR THR GLY GLN VAL VAL ALA MET LYS LYS SEQRES 4 A 302 ILE ARG LEU GLU SER GLU GLU GLU GLY VAL PRO SER THR SEQRES 5 A 302 ALA ILE ARG GLU ILE SER LEU LEU LYS GLU LEU ARG HIS SEQRES 6 A 302 PRO ASN ILE VAL SER LEU GLN ASP VAL LEU MET GLN ASP SEQRES 7 A 302 SER ARG LEU TYR LEU ILE PHE GLU PHE LEU SER MET ASP SEQRES 8 A 302 LEU LYS LYS TYR LEU ASP SER ILE PRO PRO GLY GLN TYR SEQRES 9 A 302 MET ASP SER SER LEU VAL LYS SER TYR LEU TYR GLN ILE SEQRES 10 A 302 LEU GLN GLY ILE VAL PHE CYS HIS SER ARG ARG VAL LEU SEQRES 11 A 302 HIS ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE ASP ASP SEQRES 12 A 302 LYS GLY THR ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG SEQRES 13 A 302 ALA PHE GLY ILE PRO ILE ARG VAL TYR THR HIS GLU VAL SEQRES 14 A 302 VAL THR LEU TRP TYR ARG SER PRO GLU VAL LEU LEU GLY SEQRES 15 A 302 SER ALA ARG TYR SER THR PRO VAL ASP ILE TRP SER ILE SEQRES 16 A 302 GLY THR ILE PHE ALA GLU LEU ALA THR LYS LYS PRO LEU SEQRES 17 A 302 PHE HIS GLY ASP SER GLU ILE ASP GLN LEU PHE ARG ILE SEQRES 18 A 302 PHE ARG ALA LEU GLY THR PRO ASN ASN GLU VAL TRP PRO SEQRES 19 A 302 GLU VAL GLU SER LEU GLN ASP TYR LYS ASN THR PHE PRO SEQRES 20 A 302 LYS TRP LYS PRO GLY SER LEU ALA SER HIS VAL LYS ASN SEQRES 21 A 302 LEU ASP GLU ASN GLY LEU ASP LEU LEU SER LYS MET LEU SEQRES 22 A 302 ILE TYR ASP PRO ALA LYS ARG ILE SER GLY LYS MET ALA SEQRES 23 A 302 LEU ASN HIS PRO TYR PHE ASN ASP LEU ASP ASN GLN ILE SEQRES 24 A 302 LYS LYS MET SEQRES 1 B 273 GLY SER HIS MET ASN LEU SER SER GLU TYR VAL LYS ASP SEQRES 2 B 273 ILE TYR ALA TYR LEU ARG GLN LEU GLU GLU GLU GLN ALA SEQRES 3 B 273 VAL ARG PRO LYS TYR LEU LEU GLY ARG GLU VAL THR GLY SEQRES 4 B 273 ASN MET ARG ALA ILE LEU ILE ASP TRP LEU VAL GLN VAL SEQRES 5 B 273 GLN MET LYS PHE ARG LEU LEU GLN GLU THR MET TYR MET SEQRES 6 B 273 THR VAL SER ILE ILE ASP ARG PHE MET GLN ASN ASN SER SEQRES 7 B 273 VAL PRO LYS LYS MET LEU GLN LEU VAL GLY VAL THR ALA SEQRES 8 B 273 MET PHE ILE ALA SER LYS TYR GLU GLU MET TYR PRO PRO SEQRES 9 B 273 GLU ILE GLY ASP PHE ALA PHE VAL THR ASP ASN THR TYR SEQRES 10 B 273 THR LYS HIS GLN ILE ARG GLN MET GLU MET LYS ILE LEU SEQRES 11 B 273 ARG ALA LEU ASN PHE GLY LEU GLY ARG PRO LEU PRO LEU SEQRES 12 B 273 HIS PHE LEU ARG ARG ALA SER LYS ILE GLY GLU VAL ASP SEQRES 13 B 273 VAL GLU GLN HIS THR LEU ALA LYS TYR LEU MET GLU LEU SEQRES 14 B 273 THR MET LEU ASP TYR ASP MET VAL HIS PHE PRO PRO SER SEQRES 15 B 273 GLN ILE ALA ALA GLY ALA PHE SER LEU ALA LEU LYS ILE SEQRES 16 B 273 LEU ASP ASN GLY GLU TRP THR PRO THR LEU GLN HIS TYR SEQRES 17 B 273 LEU SER TYR THR GLU GLU SER LEU LEU PRO VAL MET GLN SEQRES 18 B 273 HIS LEU ALA LYS ASN VAL VAL MET VAL ASN GLN GLY LEU SEQRES 19 B 273 THR LYS HIS MET THR VAL LYS ASN LYS TYR ALA THR SER SEQRES 20 B 273 LYS HIS ALA LYS ILE SER THR LEU PRO GLN LEU ASN SER SEQRES 21 B 273 ALA LEU VAL GLN ASP LEU ALA LYS ALA VAL ALA LYS VAL SEQRES 1 C 84 GLY PRO LEU GLY SER MET ALA HIS LYS GLN ILE TYR TYR SEQRES 2 C 84 SER ASP LYS TYR PHE ASP GLU HIS TYR GLU TYR ARG HIS SEQRES 3 C 84 VAL MET LEU PRO ARG GLU LEU SER LYS GLN VAL PRO LYS SEQRES 4 C 84 THR HIS LEU MET SER GLU GLU GLU TRP ARG ARG LEU GLY SEQRES 5 C 84 VAL GLN GLN SER LEU GLY TRP VAL HIS TYR MET ILE HIS SEQRES 6 C 84 GLU PRO GLU PRO HIS ILE LEU LEU PHE ARG ARG PRO LEU SEQRES 7 C 84 PRO LYS ASP GLN GLN LYS HET FC8 A 301 27 HETNAM FC8 ~{N}2-[(1~{R},2~{S})-2-AZANYLCYCLOHEXYL]-~{N}6-(3- HETNAM 2 FC8 CHLOROPHENYL)-9-ETHYL-PURINE-2,6-DIAMINE FORMUL 4 FC8 C19 H24 CL N7 FORMUL 5 HOH *76(H2 O) HELIX 1 AA1 SER A 0 GLU A 2 5 3 HELIX 2 AA2 PRO A 45 GLU A 57 1 13 HELIX 3 AA3 LEU A 87 ILE A 94 1 8 HELIX 4 AA4 ASP A 101 SER A 121 1 21 HELIX 5 AA5 LYS A 130 GLN A 132 5 3 HELIX 6 AA6 SER A 171 LEU A 176 1 6 HELIX 7 AA7 THR A 183 LYS A 200 1 18 HELIX 8 AA8 SER A 208 GLY A 221 1 14 HELIX 9 AA9 GLU A 230 LEU A 234 5 5 HELIX 10 AB1 LEU A 249 VAL A 253 5 5 HELIX 11 AB2 ASP A 257 LEU A 268 1 12 HELIX 12 AB3 SER A 277 ASN A 283 1 7 HELIX 13 AB4 TYR B 169 GLN B 184 1 16 HELIX 14 AB5 THR B 197 PHE B 215 1 19 HELIX 15 AB6 LEU B 218 ASN B 236 1 19 HELIX 16 AB7 PRO B 239 LYS B 241 5 3 HELIX 17 AB8 MET B 242 GLU B 259 1 18 HELIX 18 AB9 GLU B 264 THR B 272 1 9 HELIX 19 AC1 THR B 277 LEU B 292 1 16 HELIX 20 AC2 LEU B 300 GLY B 312 1 13 HELIX 21 AC3 ASP B 315 MET B 330 1 16 HELIX 22 AC4 LEU B 331 VAL B 336 5 6 HELIX 23 AC5 PRO B 339 LEU B 355 1 17 HELIX 24 AC6 THR B 361 SER B 369 1 9 HELIX 25 AC7 THR B 371 GLN B 391 1 21 HELIX 26 AC8 MET B 397 TYR B 403 1 7 HELIX 27 AC9 ALA B 404 ALA B 409 5 6 HELIX 28 AD1 LYS B 410 ASN B 418 5 9 HELIX 29 AD2 SER B 419 ALA B 428 1 10 HELIX 30 AD3 PRO C 25 LYS C 30 1 6 HELIX 31 AD4 SER C 39 GLY C 47 1 9 SHEET 1 AA1 5 TYR A 4 GLU A 12 0 SHEET 2 AA1 5 VAL A 17 HIS A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 AA1 5 GLN A 28 ILE A 35 -1 O MET A 32 N TYR A 19 SHEET 4 AA1 5 LEU A 76 GLU A 81 -1 O LEU A 78 N LYS A 33 SHEET 5 AA1 5 LEU A 66 MET A 71 -1 N GLN A 67 O ILE A 79 SHEET 1 AA2 3 MET A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 134 ILE A 136 -1 O ILE A 136 N MET A 85 SHEET 3 AA2 3 ILE A 142 LEU A 144 -1 O LYS A 143 N LEU A 135 SHEET 1 AA3 3 VAL A 124 LEU A 125 0 SHEET 2 AA3 3 ARG A 151 ALA A 152 -1 O ARG A 151 N LEU A 125 SHEET 3 AA3 3 ILE A 155 PRO A 156 -1 O ILE A 155 N ALA A 152 SHEET 1 AA4 3 TYR C 7 TYR C 8 0 SHEET 2 AA4 3 TYR C 17 MET C 23 -1 O MET C 23 N TYR C 7 SHEET 3 AA4 3 TYR C 12 PHE C 13 -1 N TYR C 12 O TYR C 19 SHEET 1 AA5 4 TYR C 7 TYR C 8 0 SHEET 2 AA5 4 TYR C 17 MET C 23 -1 O MET C 23 N TYR C 7 SHEET 3 AA5 4 GLU C 63 PRO C 72 -1 O PHE C 69 N ARG C 20 SHEET 4 AA5 4 VAL C 55 HIS C 60 -1 N VAL C 55 O ARG C 70 CISPEP 1 PRO A 246 GLY A 247 0 -11.58 SITE 1 AC1 10 ILE A 10 ALA A 31 PHE A 80 GLU A 81 SITE 2 AC1 10 LEU A 83 SER A 84 MET A 85 ASP A 86 SITE 3 AC1 10 GLN A 132 LEU A 135 CRYST1 64.513 68.205 166.086 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015501 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014662 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006021 0.00000